CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- 4 Grant or award Chief Commercial Officer acquired 30,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Finance and CFO sold 3,928 shares at $39.68 ($155,863)
- 4 Open-market buy Chief Executive Officer bought 27,800 shares at an average $35.57 ($988,882)
- 4 Exercise or conversion Director acquired 24,000 shares (option exercise)
- 4 Shares withheld for taxes SVP, China Operations gave up 3,038 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Finance and CFO gave up 2,156 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 3,292 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Clinical Dev, Drug Safety gave up 2,728 shares (to pay taxes)
- 4 Grant or award Director acquired 4,700 shares (grant or award)
- 4 Grant or award Director acquired 4,700 shares (grant or award)
- 4 Grant or award Director acquired 4,700 shares (grant or award)
- 4 Grant or award Director acquired 4,700 shares (grant or award)
- 4 Grant or award Director acquired 4,700 shares (grant or award)
- 4 Grant or award Director acquired 4,700 shares (grant or award)
- 4 Grant or award Director acquired 4,700 shares (grant or award)
- 4 Grant or award Director acquired 4,700 shares (grant or award)
- 4 Grant or award Director acquired 4,700 shares (grant or award)
- 4 Grant or award Director acquired 4,700 shares (grant or award)
- 4 Open-market sale Director sold 18,000 shares at $23.17 ($417,074)
Page 13 of 38 · 760 filings